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While  there  is increasing  attention  to  cancer  among  underserved  populations  globally,  recent  publica-
tions have  suggested  that  discussions  often  ignore  the  broad  but  critical  issues  and  lack  due diligence.
This  communication  considers  these  subjects.  We  all  seek  honest  governments,  recognition  of  women’s
and other  human  rights,  protection  of  minorities,  the  fostering  of  education  for  all,  and  the  rendering
of  fair  justice.  Absence  of  these  overwhelms  efforts  in  cancer  care.  Massive  rural-urban  migration  and
the  majority  of  cancer  burdens  globally  occurring  among  the  huge  populations  of  poor  Asians  are  also
dominating  realities.  In-depth  understanding  of  how  people  actually  live  must  ground  our  efforts.  Weak
governments,  weak  health  systems,  and  widespread  corruption  adversely  impact  work  to  improve  cancer
outcomes.
Some  implications  of  these  painful  circumstances  are  ﬁrst  that  cancer-speciﬁc,  top-down  approaches
may  be less  suitable  and  less  effective  than  locally  deﬁned  efforts  sensitive  to  particular  broad  issues.ess-developed countries
ocioeconomic status
ancer
Second,  that  widespread  drug  availability  may  be  less  an economic  issue  than  a social  systems  issue.
Third,  patient  education  about  cancer  signs  and  symptoms  may  be less  useful  than  direct  efforts  targeting
broad human  rights  issues  to  give  patients  real  choices  to seek  care.
We  suggest  that  addressing  cancer  control  for  underserved  populations  needs  to  be more  of  an  exercise
in addressing  the  major  societal  issues,  living  noble  values,  investigating  to see things  as  they  really  are,
and acting  from  a  model  of  intervention  suitable  to the  broad  complex  challenges.© 2013 The Authors. Published by Elsevier Ltd. 
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Table 1
Population estimates (in billions = B) for 8 largest countries in 2005 (2).
1. China 1.31 B
2. India 1.03 B
3. U.S.A. 0.29 B
4. Indonesia 0.23 B Global population: 6.5 B
5.  Brazil 0.186 B Top South and East Asian (top 5 of 8): 2.9 B
6.  Pakistan 0.157 BR.R. Love et al. / Journal of Ca
ntroduction
While there is increasing speciﬁc attention to non-
ommunicable diseases, including cancer, among marginalized
opulations, most codiﬁed by the ﬁrst dedicated UN Conference in
eptember 2011, in the considerations there is minimal attention
o the broad societal challenges so critical to meaningful changes
or populations affected by chronic diseases [1]. Globally, cancer
s now the second leading cause of death [2]. Of the cancer global
urdens, 50% of all new cases and 66% of all cancer deaths occur
n citizens of low- and middle-income countries (LMCs) and these
ercentages are projected to be 70% and 80% respectively by 2020
3]. In the United States 17% of the population is uninsured and
lose to twice this percentage is underinsured. While teasing out
ancer speciﬁc associations among such populations is difﬁcult,
sing the socioeconomic status surrogate of education, higher
ancer death rates are associated with lower levels of education,
nd minority populations including American Indians have lower
 year cancer survival rates [4,5]. Some recent publications suggest
ow we might better frame our discussions to address these
merging and challenging burdens both across the globe and
ithin the United States.
In considering the challenges of cancer in poor populations what
s striking are the topics we choose to discuss and not to discuss.
e tend to spend the largest fraction of meeting time reviewing
he known descriptive epidemiology of cancer and the state-of-the
rt in causative biology, and relatively little, or in many circum-
tances no time at all reﬂecting on the general challenges of societal
evelopment and the major ways in which these impact cancer
ealth adversely. Nigel Crisp’s recent treatise “Turning the world
pside down” is primarily about this very broad framework [6].
n avoidable problem is tone of superiority and arrogance from
igh-income country experts about what needs to be done, as
risp’s multiple anecdotes suggest [6]. At some level, this is fail-
ng to meet our intellectual obligations for due diligence. Recently,
eju Cole caustically, but compellingly and persuasively argues that
uch limited approaches have all too often characterized our west-
rn efforts to help in addressing social problems [7]. The products
f such meetings have an absence of nuance in “recommenda-
ions”. As an example, the report in the news of a recent conference
ocused on guidelines for management of metastatic breast can-
er globally [8]. In the albeit-limited reported material from this
ctivity, the complexities of health care and societies noted so com-
rehensively by Crisp were not addressed and discussions of the
xtreme differences in how components of cancer care are paid for
mong populations was absent. Our sense at times is a misplaced
earning for simplicity. Here then we consider brieﬂy the usually
idestepped, politically sensitive issues.
eneral goals for all societies, and major demographic
ealities
As Thomas Friedman has repeatedly written, what we  are striv-
ng for everywhere are more widespread national models under
hich there are institutions that deliver honest government, rec-
gnize women’s and other human rights, protect minorities, foster
ducation for all, and render fair justice. Instead, in much of the
orld and in poorer communities in the United States we have
apricious societies of uncertainty and few ﬁrm assumptions, soci-
ties in which all ﬁght for the smallest gains; societies without
onsensual politics and where there is little working together
or common goals. A comprehensive and dramatic description of
uch circumstances in a low-income country setting is provided in
atherine Boo’s non-ﬁctional account of life in a Mumbai slum [9].7.  Russia 0.143 B
8.  Bangladesh 0.141 B
There are two  demographic issues that deserve our greater
attention. First, we  are in the midst of a period of huge rural to urban
migration [10]. While in high-income countries, population distri-
butions are now 75% urban 25% rural, in many large low-income
countries (Bangladesh for example), the distributions are reversed.
Across the planet, rural life is dangerous to health, and projections
are that we  are rapidly moving to high-income country population
distributions in many low-income populous countries. The newly
created neighborhoods or cities into which these rural migrants
come (and go intermittently) need to be more in our calculus about
addressing health generally and cancer [10].
Second, often the discussions of cancer in poorer populations
are dominated by considerations of the challenging circumstances
and large disease burdens in Africa. As Table 1 suggests however,
more than half of the world’s population lives in South and East
Asian countries.
In the United States it is estimated that there are 50 million
uninsured and poor people [4]. The implications of these numbers
should be evident: if we are going to make a difference, have a global
impact, or change the current “slow-motion disaster”, Asia and our
own  American communities deserve a lot more attention [1].
How general issues impact health: three examples
Our discussions about changing and improving lives touched by
cancer in poorer populations have to begin with signiﬁcant under-
standing of inhabitant’s lives as they are now. Doug Eby, who  works
with Alaskan native populations, states, “the primary diagnosis is
social” (As quoted by Crisp, p. 133, 6). In fairness, it is asking a
lot of us from high-income countries that we  know much at all
about the details of poor peoples’ live, but various authors are pro-
viding us with greater insights. As noted above, Katherine Boo’s
account of life in a Mumbai slum offers rich information on the
intertwined adversities of poverty, gender and religious discrimi-
nation, and cultural perceptions of a “husk of an existence” or that
people themselves do not believe that their lives matter even to
them (reﬂected in frequent suicides for example which are likely far
more common in poor under-societies that is usually appreciated
(commenting on suicide among poor Indian farmers) (9, p. 147).
The consequences of human rights shortcomings are brutal and
ugly lives for a large fraction of our global population. Our frame-
works for thinking about cancer must be sensitive to these painful
circumstances. From the generally comfortable lives of oncology
physicians, it is far too easy to make assumptions about how things
work among other populations.
Second, a major consequence of weak governments is the
presence of weak health systems, which are underfunded and
dysfunctional—this is true in LMCs and among various American
communities—the Indian community in the United States is an
example. When the annual Indian Health Service (IHS) budget ﬁg-
ures are adjusted for inﬂation, it becomes apparent that the per
capita spending power with IHS appropriations in 1996 dollars
is roughly the same today as it was in 1991, while the costs for
services have increased [11]. In many poor countries, alternative
private-for-the-rich “systems” have developed, whose existence
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asks to outsiders the non-existence of a real public-serving, func-
ional system.
Third, a ubiquitous consequence of weak national institutions in
any LMCs is widespread corruption. As Nicholas Kristof has writ-
en about China: “Even good people are on the take in China these
ays, because everybody else is” (The New York Times 4/22/12).
he translation of this, as Boo has so dramatically portrayed, is that
lso for most poor people in LMCs life is a market, in that everything
s up for sale. Daily life is an unpredictable venture. We  can respond
hat of course there is corruption everywhere; extent and perva-
iveness through all of life is the issue. In LMCs medicine, there
re webs, and pervasive societal corruption. We  need to under-
tand better and consider the patterns of power and their corrupt
xpression throughout medical systems. Boo notes: “The effect of
orruption that I ﬁnd most under-acknowledged is a contraction
ot of economic possibility, but of our moral universe” (9, p. 253).
etting more light shine on these issues and peoples may  be a key
o the eventual lessening of their grip.
iscussion: implications
First and our major points are that in considering activities
n addressing cancer among poor populations, more discussion
f these general goals and issues and greater due diligence are
eeded. Workers in global cancer health need more ﬁeld experi-
nces that might leave them feeling as though they had traveled
ackwards in time, but are absolutely essential to getting better
nsight into the “usual” courses of things. This should not be so
trange to practicing doctors who know that descriptions by others
f patient problems often miss the critical issues and facts, which
re only appreciated when the patient herself is seen face-to-face.
ur “direct “approaches to cancer control problems can be undone,
hwarted, and can instead make things worse because of assump-
ions about general circumstances which would not occur if we had
one more “homework”. We  suggest the following as examples:
. Well-intentioned work to address cancer in LMCs often includes
efforts to deﬁne “guidelines” for diagnosis and treatment. The
Institute of Medicine (IOM) framed the major issues for LMCs
in cancer control as “national decisions” and priorities of the
“global health community” [12]. The ﬁrst recommendation in
the IOM report is for national cancer control plans (12, p. 5).
We  submit that while some “top-down” national, internationally
funded activities which might successfully address major cancer
control issues, can be identiﬁed a priori (tobacco issues for exam-
ple), there is a compelling need in LMCs and poorer communities
in the United States to deﬁne local community, population-
directed interventions across the spectrum [6]. When speciﬁc
cancer control activities start at the community level, commu-
nities themselves help ﬁgure out how to address the named major
determinants of success (that is communities make and address the
primary social diagnoses).  In the face of general societal short-
comings and the adverse impact of these on health noted above,
determination of national plans and guidelines are of limited
value in large LMCs. In our view the repeated promulgation of
this recommendation or ﬁrst step for better cancer control in
LMCs is inappropriate, particularly in the face of a complete
absence of evidence for favorable impact in LMCs. The call for
national cancer control plans is regularly accompanied by sug-
gestions that better descriptive data are needed ﬁrst, when the
broad scope of cancer and its causes across almost all popula-
tions is already well known. It is this kind of top down emphasis,
which Crisp also, ﬁnds so ineffective [6].
. A perceived common problem is unavailability of drugs for sys-
temic therapy of cancer in poorer countries and communities.olicy 1 (2013) e20– e24
One assumption is that costs are in fact a major issue, a solution
to which is donation of drugs; associated is a second assumption
that a secure supply chain to deliver such donations can be devel-
oped. In fact to take examples from one country, Bangladesh, the
direct costs of drugs for three common breast cancer treatments
are cyclophosphamide, methotrexate, 5-ﬂuorouracil (CMF) for
4 cycles is $100; Doxorubicin, cyclophosphamide (DC) for 4
cycles is $160; and Paclitaxel for 12 weekly cycles is $1000.
In the current market (“stated market”—it is very difﬁcult to
ﬁnd out about all hidden charges and costs) in Bangladesh,
20–50% of chemotherapy treatment charges at maximum (but
likely the real percentage is less) are for drugs; the remainder
are for supplies, and “professional” and other fees. Opera-
tionally, it is difﬁcult to imagine being able to provide these
drugs from outside Bangladesh at lower prices. Further were
drugs to be sent from out-of-country to Bangladesh, secure
supply chains are very challenging (in the same way that for
many countries the mosquito protection from malaria bed-
nets “donated” does not occur—the nets are found in markets
for sale). The truth then seems to be that these chemother-
apy treatments do not get given because of the broader issues:
health system inefﬁciencies, human rights issues and admin-
istration/governance/corruption/hidden charges problems. A
common focus on the issues of the new expensive (and
presumed effective in LMC  circumstances—ethnic, nutritional,
co-morbidities) drugs, “unavailable” to poorer populations,
seems misplaced in light of these realities; in many LMCs and
for poorer populations, we  do not know how to ensure treatment
with basic drugs when they are available.
3. A major concern is that overwhelming ﬁnancial resources are
what is needed and there is no way  these can be made avail-
able, and therefore we should move on to addressable problems.
But do we,  would we  really know exactly what to do with
major ﬁnancial resources to provide more “cancer health” to
populations in LMCs and poorer US communities, were they pro-
vided? Could we  point to stage one (demonstration) or stage
two (rigorous evidence from a randomized trial) to justify scal-
ing up an intervention to population affecting level in much
different settings, with genetically/ethnically nutritionally/co-
morbidity-different populations? Additional ﬁnancial resources
are needed but for precisely the indicated kind of on-the-ground,
local experiments.
4. Finally there seems to be a universal perception that the very real
problem of late presentation with advanced disease that so much
characterizes cancer in poorer populations needs to be addressed
with patient education. As we  have reported for Bangladesh, in
fact women are very aware of the serious problems they have
with growing breast masses, but feel they have no choices to
speciﬁcally address these problems [13]. Harford has analyzed
the “early detection” possibilities for breast cancer in LMCs and
found little evidence that intense efforts might be useful [14].
The larger issues that affect access to basic care are the pivotal
ones in addressing late presentations.
A broader view
How then should we be thinking about the cancer challenges
for poor populations? The status quo must be recognized as unac-
ceptable. First, we  believe that we need to be acting on and living
our values quietly, respectfully, out of appropriate anger, but con-
tinually, for the long haul. As a commenter on how to help suggests
success involves “abundance of humility, high tolerance for uncer-
tainty and complexity, patience in understanding context, and
willingness to listen to the people who live with the problems” [15].
The distance from large value issues in our conversations very much
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uggests that we need some disruptive change in our value expres-
ion. We  have healthcare systems in which money is the only, or
f not the massively overwhelming, coin of the realm. As a general
remise, academia rewards those who publish, teach and earn rev-
nue with little value placed on service to the underserved, which
ay  even be considered detrimental to academic advancement as
 “waste of time”. There are striking examples of pioneers whose
ersonal efforts have driven substantially new thinking, however,
hat one can name but a few of these individuals speaks to the
eed [16]. Further, these must be sustainable beyond the life of
he founder. We  need more talk about the broader and politically
ensitive issues.
Second, to decrease the likelihood of making things worse,
nd wasting effort we need to better practice due diligence
nd acknowledge what we do not know. We  need to have
ore honest and open discourse and to limit distracting
nd central issue-deﬂecting talk. We  should adopt a more
nvestigative-journalist inquisitive, listening, rigorous, complexity-
cknowledging, ingénue mind set. Broad cultural differences in
ommunication and norms separate high-income (primarily west-
rn) and LMC  country peoples. We  need to broaden our “expert”
nvolvement—seeking help from sociology, anthropology, psychol-
gy and business among other disciplines [17,18].
Third, we need to consider deﬁning an intervention “model” for
hatever area we choose to work in, in which we  describe how we
hink things work; a model which provides the rationale for our
roposed intervention or activity in a particular situation, instead
f a one shoe-ﬁts-all assuming approach. In developing the idea of
n International Cancer Experts Corps (ICEC), we have suggested a
odel which might “facilitate better outcomes from cancer from
he inside out”, based on a US community development model
ffered by Kretzman and McKnight [19].
The model proposes international expert individuals and teams
o partner for community development for cancer to:
I. Rally community leaders to possibilities of better cancer and
medical care;
II. Facilitate community development by helping leaders to recog-
nize all community assets, build community relationships, and
create a community vision and plan; and
II. Partner to leverage outside investments and resources and real-
ize the plan.
Much of the model is bi-directional education with the resource-
ich partner learning what the issues are on the ground, while
roviding the mentoring so important to success in almost any
ndeavor in life-science, sports, business, and the arts. Mentoring is
 time-honored successful use of time [20]. A sustainable partner-
hip will depend on the ability of both mentors and mentees to do
his work as part of their careers, because it is valued and rewarded,
he latter with time and recognition, not merely money.
We have applied this model in beginning to address the chal-
enge of case—ﬁnding for breast cancer in rural Bangladesh using
ommunity health workers, and in working with the Lakota Sioux
ndian population in South Dakota [21–23]. Such work has applied
his broader conceptual model in a narrower “implementation
cience” efforts. The development of the latter Sioux Indian pro-
ram took two years and involved multiple listening and gaining
rust meetings with tribal leaders and community members, which
ctivities are so essential to sustainable relationships. Four rigorous
esearch projects were deﬁned and successfully conducted demon-
trating that major beneﬁts and improvements in cancer care can
ome to underserved populations [23,24].
Finally, we need to acknowledge the need for and seek help to
eﬁne an ethical model within which to work on the challenging
roblems of inequalities in health resources in the same way thatolicy 1 (2013) e20– e24 e23
Stephen Gardiner has suggested is necessary to move forward our
engagement with climate change [25]. A speciﬁc challenge with
respect to cancer in LMCs illustrates the dilemmas. In many LMCs
there is a dearth of facilities for radiation therapy; in Bangladesh,
for example, there are about 18 operating machines in the entire
country when based on disease and stage burdens, it can be esti-
mated that perhaps 300 are needed. The adverse consequences for
the majority of patients with cancer are great [26]. The commonest
malignancies, for women of the breast and uterine cervix and for
men of the head and neck, are curable with radiation therapy, even
in advanced stages. The capital costs for creating a facility are about
$1.3–1.8 million for a regulatory standards-meeting building and
equipment. The long term beneﬁts that might accrued to treated
populations of patients are in fact large in relation to these capi-
tal costs; large numbers of quality life years of life might be saved
at strikingly low costs per life/year/saved, and signiﬁcant fractions
of patients with common malignancies might be cured despite
advanced stages of disease at diagnosis, or signiﬁcantly relieved
of pain, bleeding, dyspnea, or dysphagia. A social business model
for such facilities which projects sustainability after an investment
covering most of the capital cost is not difﬁcult to write. The crunch
issue, essentially a moral issue, then is where should the capital
investment ﬁnancing come from? What is our ethical model for
considering how should such global inequities in health be cor-
rected?
Mechanisms and conclusions
Who  needs to do what? University global health programs need
to be more than about how to meet our students’ increasing inter-
ests and to go beyond as a ﬁrst “requirement” what we can get out
of international collaborations [6].
National institutions need to create new mechanisms for global
health research out of a clear necessity in science, out of selﬁsh
interest, that if we  do not partner with others, we cannot maintain
our cutting edge positions in science [27].
International efforts can complement, supplement and be
modeled on the lessons from the Program of Action for Cancer Ther-
apy (PACT) of the International Atomic Energy Commission (IAEA)
[28]. PACT has created the imPACT-integrated missions of PACT
review process to identify most pressing cancer care needs; PACT
model demonstration sites; and Regional Cancer Training Networks
with a Virtual University for Cancer Control.
Current models of healthcare can only become more expensive
unless there are other forms of compensation. Such compensa-
tion could be in the form of academic advancement for altruistic
service. Healthcare professional will seek positions that may have
lower salaries but include time to serve the community when this
is valued [29]. This kind of activity is a type of disruptive change
Christensen has described as so useful in other industries [17].
But above all, in the professional oncology community as we
meet, write, discuss and act to meet these challenges, we need to be
more open and broad in the subjects of our discourse, and practice
more due diligence in our activities.
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